Oxidative damage increases with age in a canine model of human brain aging

Journal of Neurochemistry

Volumn 82, Issue 2, 2002, Pages 375-381

  Head, E ^a   Liu, J ^b   Hagen, T M ^c   Muggenburg, B A ^d   Milgram, N W ^e   Ames, B N ^b   Cotman, C W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dog; Glutamine synthetase; Glutathione; Malondialdehyde; Protein carbonyls; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; CARBONYL DERIVATIVE; GLUTATHIONE; LIPID; MALONALDEHYDE; PROTEIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN DEGENERATION; BRAIN LEVEL; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; DOG; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; CEREBROSPINAL FLUID; DOGS; GLUTAMATE-AMMONIA LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATION-REDUCTION; PREFRONTAL CORTEX; PROTEINS; TIME;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036069450     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00969.x     Document Type: Article

References (46)

1. Oxidants, antioxidants, and the degenerative diseases of aging
2. The free radical theory of aging matures
3. Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches
4. Protein oxidation in aging, disease, and oxidative stress
5. Neuropathological stageing of Alzheimer related changes
6. Neurobehavioral aspects of antioxidants in aging
7. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-a-phenylnitrone
8. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine
9. The canine as an animal model of human aging and dementia
10. Diffuse plaques contain C-terminal A beta 42 and not A beta 40: Evidence from cats and dogs
11. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
12. Oxidative biochemical markers; clues to understanding aging in long-lived species
13. Protein degradation by the proteasome and its implications in aging
14. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative
15. Visual-discrimination learning ability and beta-amyloid accumulation in the dog
16. Region-specific age at onset of β-amyloid in dogs
17. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
18. Astrocytes: Glutamate producers for neurons
19. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
20. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis
21. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
22. Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by γ-radiolysis of water
23. Immunohistochemical detection of anti-oxidative stress enzymes in the dog brain
24. Carbonyl assays for determination of oxidatively modified proteins
25. Stress, aging, and brain oxidative damage
26. Assay of aldehydes from lipid peroxidation: Gas chromatography-mass spectrometry compared to thiobarbituric acid
27. The effects of aging on hematology and serum chemistry values in the beagle dog
28. Oxidative stress hypothesis in Alzheimer's disease
29. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
30. Cognitive functions and aging in the dog: Acquisition of nonspatial visual tasks
31. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
32. Increased CSF F2-isoprostane concentration in probable AD
33. Amyloid precursor protein, copper and Alzheimer's disease
34. Glutathione status and reactive oxygen generation in tissues of young and old exercised rats
35. Oxidative injury in diseases of the central nervous system: Focus on Alzheimer's disease
36. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer's amyloidosis
37. Ageing choroid plexus-cerebrospinal fluid system
38. Restriction of energy intake, energy expenditure, and aging
39. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides
40. Glutamine synthetase
41. Glutathione in human plasma: Decline in association with aging, age-related macular degeneration, and diabetes
42. Inactivation of mammalian brain glutamine synthetase by oxygen radicals
43. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
44. Oxidative stress and aging in the Mongolian gerbil (Meriones unguiculatus)
45. Protein oxidation
46. Aged dogs: An animal model to study β-protein amyloidogenesis